0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Invited Commentary |

We Need to Be Better Prepared for Hydroxychloroquine Retinopathy

Hendrik P. N. Scholl, MD, MA1; Syed Mahmood Ali Shah, MBBS1
[+] Author Affiliations
1Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland
JAMA Ophthalmol. 2014;132(12):1460-1461. doi:10.1001/jamaophthalmol.2014.4090.
Text Size: A A A
Published online

Extract

From the first discovery of chloroquine by Hans Andersag at Bayer in 1939 and later development of its hydroxyl and less toxic form hydroxychloroquine (HCQ), these medications have been one of the most abundantly used around the world and have been instrumental in saving countless lives from malaria. Hydroxychloroquine is currently listed in the World Health Organization Model List of Essential Medicines as a disease-modifying agent for rheumatoid arthritis. Its use is becoming ubiquitous for a variety of autoimmune disorders from lupus to rheumatoid arthritis and now finding its way into dermatology and oncology.1 There are more than 50 studies evaluating HCQ in various disorders including many tumors. With the results of the LUMINA (Lupus in Minorities: Nature vs Nurture) trial showing clear benefit of HCQ use by decreasing mortality and end organ damage, HCQ use has significantly increased and is being advocated by the rheumatology community with clinical trials reporting its use in 50% of patients with lupus, with tertiary care centers reporting the rate of up to 90% (Baltimore Lupus Cohort; Michele Petri, MD, MPH, Johns Hopkins Hospital, written communication, June 25, 2014). Given the increasing use of HCQ and retinopathy being the only absolute contraindication for its use, it is more critical than ever to advocate for screening, detection, and prevention of retinopathy. Of note, most of these screenings are not performed by retina specialists but by general ophthalmologists.2

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

1,161 Views
0 Citations
×

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles
Jobs
brightcove.createExperiences();